Altoida Raises $6.3M Series A to Predict Alzheimer's Disease Risk Using Artificial Intelligence, Machine Learning and Augmented Reality | Venture Incubator
Altoida Receives Investment from Alzheimer's Drug Discovery Foundation
Ioannis Tarnanas Altoida Inc. - PMWC Precision Medicine World Conference
Altoida's Alzheimer's-predicting smartphone app snags FDA breakthrough status | Fierce Biotech
Altoida AG - Venture Kick
Ioannis Tarnanas - Worldwebforum
Cognitive Health & Digital Biomarker Technologies | Altoida
Altoida secures funding and research partnership with Eisai Innovation – Venturelab
Alzheimer's detection platform Altoida raises $6.3M in Series A funding | MobiHealthNews
Alzheimer's detection platform Altoida raises $6.3M in Series A funding | MobiHealthNews
Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases - Essentials
Cognitive Health & Digital Biomarker Technologies | Altoida
Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases - Essentials
Altoida raises $6.3M Series A for AI Alzheimer's risk predictor - MassDevice
Tweets with replies by Altoida, Inc. (@altoida) / Twitter
Altoida Chief Science Officer Ioannis Tarnanas to Keynote at Worldwebforum - Worldwebforum
Ο Έλληνας ερευνητής Ιωάννης Ταρνανάς κατέκτησε το κορυφαίο ευρωπαϊκό βραβείο καινοτομίας! Προβλέπει το Αλτσχάιμερ στα 6 χρόνια (Φωτό & Βίντεο) | eirinika.gr
Altoida, Inc. (@altoida) / Twitter
A brain fitbit that can spot Alzheimer's with up to 94% accuracy
Ioannis Tarnanas's email & phone | Altoida's Founder email
Altoida Chief Science Officer Ioannis Tarnanas to Keynote at Worldwebforum - Worldwebforum
Cognitive Health & Digital Biomarker Technologies | Altoida
Ioannis Tarnanas - Worldwebforum
Altoida - Diagnosing Alzheimer's Disease 5 years prior to it's onset using Augmented Reality on your iPhone | Startup Ranking
Altoida secures funding and research partnership with Eisai Innovation
